Advancing biologics and vaccine delivery with Microneedle Array Patch (MAP) Technology

In our webcast Dr. May Pidding explains how clinically needs-driven formulation design and advanced delivery technologies can shape the future of biologics and vaccine administration. Microneedle Array Patch (MAP) technologies have emerged as a groundbreaking platform for transdermal and intradermal drug delivery and are at the forefront of pharmaceutical innovation – improving efficacy, safety, and patient compliance. MAPs represent a next-generation approach to biologic and vaccine delivery. By enabling painless, transdermal administration, MAPs can overcome key challenges of traditional injections, including pain and poor patient adherence.

Language: EN with Chinese Subtitles

Presented by: May Pidding